{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:59:55Z","timestamp":1788587995672,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jim.2021.113082","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T11:31:16Z","timestamp":1622028676000},"page":"113082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies"],"prefix":"10.1016","volume":"495","author":[{"given":"Etienne","family":"Frumence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gorie","family":"Lebeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wildriss","family":"Viranaicken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Dobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Vagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahary","family":"Lalarizo Rakoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Sandenon Seteyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Giry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Septembre-Malaterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Raffray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gasque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2021.113082_bb0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0006-291X(02)00566-1","article-title":"Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression","volume":"294","author":"Barash","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jim.2021.113082_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/jiaa273","article-title":"Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019","volume":"222","author":"Burbelo","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2021.113082_bb0015","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/emmm.201201379","article-title":"Fc-fusion proteins: new developments and future perspectives","volume":"4","author":"Czajkowsky","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jim.2021.113082_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jmb.2007.11.081","article-title":"Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS coronavirus infection","volume":"376","author":"Diemer","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jim.2021.113082_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7020055","article-title":"A chimeric Zika virus between viral strains MR766 and BeH819015 highlights a role for E-glycan loop in antibody-mediated virus neutralization","volume":"7","author":"Frumence","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.jim.2021.113082_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-1119(90)90091-5","article-title":"Use of the human elongation factor 1\u03b1 promoter as a versatile and efficient expression system","volume":"91","author":"Kim","year":"1990","journal-title":"Gene"},{"key":"10.1016\/j.jim.2021.113082_bb0035","first-page":"21","article-title":"Deciphering SARS-CoV-2 Virologic and immunologic features","author":"Lebeau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jim.2021.113082_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/422040","article-title":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid","volume":"190","author":"Leung","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2021.113082_bb0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2021.113082_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbrc.2008.09.153","article-title":"SARS coronavirus: unusual lability of the nucleocapsid protein","volume":"377","author":"Mark","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jim.2021.113082_bb0055","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jim.2021.113082_bb0060","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1128\/JVI.79.17.11476-11486.2005","article-title":"The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation","volume":"79","author":"Surjit","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2021.113082_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jim.2021.113082_bb0070","first-page":"1","article-title":"COVID-19 in early 2021: current status and looking forward","volume":"6","author":"Wang","year":"2021","journal-title":"Sign. Transduct. Target. Ther."},{"key":"10.1016\/j.jim.2021.113082_bb0075","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nbt1026","article-title":"Production of recombinant protein therapeutics in cultivated mammalian cells","volume":"22","author":"Wurm","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jim.2021.113082_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00932","article-title":"Immunization with fc-based recombinant Epstein\u2013Barr virus gp350 elicits potent neutralizing humoral immune response in a BALB\/c mice model","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2021.113082_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921001277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921001277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:28:03Z","timestamp":1762205283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175921001277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":17,"alternative-id":["S0022175921001277"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2021.113082","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2021.113082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113082"}}